ALT Altimmune
Altimmune earnings company data as of 4:00 PM ET 11/1
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | -0.14 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by ALT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $370K bought by 6 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Jerome Benedict Durso CEOBuy$44K 15,000 shares at $2.95 +32% to stakeTraded Aug 13 Filed Aug 13
-
John Gill DirectorBuy$31K 9,200 shares at $3.41 +74% to stakeTraded Apr 6 Filed Apr 6
-
Jerome Benedict Durso CEOBuy$47K 15,000 shares at $3.14 +46% to stakeTraded Apr 1 Filed Apr 1
-
Gregory L Weaver CFOBuy$31K 10,000 shares at $3.15 +36% to stakeTraded Apr 1 Filed Apr 1
-
Jerome Benedict Durso CEOBuy$71K 20,000 shares at $3.54 +160% to stakeTraded Mar 6 Filed Mar 9
-
Gregory L Weaver CFOBuy$18K 5,000 shares at $3.54 +22% to stakeTraded Mar 6 Filed Mar 9
-
Wayne Pisano DirectorBuy$20K 5,000 shares at $4.08 +59% to stakeTraded Jan 8 Filed Jan 9
-
Catherine A. Sohn DirectorBuy$2,118 500 shares at $4.24 +50% to stakeTraded Jan 5 Filed Jan 5
-
Diane Jorkasky DirectorBuy$2,003 527 shares at $3.80 New stakeTraded Dec 29, 2025 Filed Dec 29, 2025
-
John Gill DirectorBuy$51K 12,500 shares at $4.10 New stakeTraded Dec 23, 2025 Filed Dec 23, 2025
-
Jerome Benedict Durso DirectorBuy$52K 12,500 shares at $4.13 New stakeTraded Dec 22, 2025 Filed Dec 22, 2025
Also filed in the last 12 months, not counted as buying or selling: 14 share withholdings for taxes, 14 option exercises, and 5 stock grants.
SEC filings
Recent issuer filings from EDGAR, 21 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.03 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 424B5 | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 424B5 | Filing Doc | ||
| 8-K | 5.03,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon